We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

17 hedge funds and large institutions have $1.28M invested in Cocrystal Pharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

6% more funds holding

Funds holding: 16 → 17 (+1)

0.38% more ownership

Funds ownership: 6.92% → 7.3% (+0.38%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

3% less capital invested

Capital invested by funds: $1.32M → $1.28M (-$41.1K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$132K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.44K
3
JP Morgan Chase
JP Morgan Chase
New York
+$804
4
UBS Group
UBS Group
Switzerland
+$297
5
Wells Fargo
Wells Fargo
California
+$5

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$66.9K
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.96K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$325
4
AIC
Archer Investment Corporation
Indiana
-$157
5
Bank of America
Bank of America
North Carolina
-$87
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$475K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$215K -$1.96K -1,100 -0.9%
Morgan Stanley
3
Morgan Stanley
New York
$204K +$132K +74,101 +167%
BlackRock
4
BlackRock
New York
$128K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$103K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$58.7K -$66.9K -37,635 -52%
State Street
7
State Street
Massachusetts
$41.6K – – –
Northern Trust
8
Northern Trust
Illinois
$21K – – –
Bank of America
9
Bank of America
North Carolina
$15.5K -$87 -49 -0.5%
TRCT
10
Tower Research Capital (TRC)
New York
$10.1K +$4.44K +2,496 +75%
JP Morgan Chase
11
JP Morgan Chase
New York
$3.73K +$804 +452 +26%
VL
12
Vima LLC
Michigan
$387 +$400 +225 New
UBS Group
13
UBS Group
Switzerland
$288 +$297 +167 New
Wells Fargo
14
Wells Fargo
California
$159 +$5 +3 +3%
NL
15
NVWM LLC
Pennsylvania
$145 – – –
Fidelity Investments
16
Fidelity Investments
Massachusetts
$7 -$325 -183 -98%
AIC
17
Archer Investment Corporation
Indiana
– -$157 -84 Closed

COCP Hedge Fund Activity: Q4 2023 in Review

17 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q4 2023, worth a combined $1.28M — down 3.1% from $1.32M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new COCP positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $132K. The largest seller was Susquehanna International Group, cutting an estimated $66.9K.

  • 17 institutional investors held Cocrystal Pharma (COCP) as of Q4 2023, up from 16 in Q3 2023.
  • Funds reported $1.28M of Cocrystal Pharma stock for Q4 2023, down 3.1% quarter-over-quarter.
  • 2 funds opened new Cocrystal Pharma positions in Q4 2023 and 1 closed out, a net change of +1 holder.
  • The largest Cocrystal Pharma buyer in Q4 2023 was Morgan Stanley, an estimated $132K added.
  • The largest Cocrystal Pharma seller in Q4 2023 was Susquehanna International Group, an estimated $66.9K sold.

Based on aggregated 13F filings for Q4 2023.